Metagenomic sequencing could prove especially beneficial for prognosis when the affected person is immunocompromised. An ever-broader variety of infectious agents could cause severe hurt to people today with immunosuppression, so clinical screening should usually be broader. Additionally, the expression of symptoms is usually atypical, making a med